3Greenlee RT,Murrtay T,Bolden S,et al.Cancer statistics,2000.CA Cancer J Clin,2000,50(1):7-33.
4Denmeade SR,Isaacs J1r.A history of prostate cancer treatment.Nat Rev Cancer,2002,2(5):389-396.
5Vignot S,Faivre S,Agnirre D,et al.mTOR-targeted therapy of cancer with rapamyein derivatives.Ann Oncol,2005,16(4):525-537.
6Ruvinsky I,Sharon N,Lerer T,et al.Ribosomal protein S6 phosphorylation is a determinant of cell size and gIuc08e homeostasis.Genes Dev,2005,19(18):2199-2221.
7Jaeinto E,Hall MN.Tor signalling in bugs,brain and brawn.Nat Rev Mol Cell Biol,2003,4(2):117-126.
8Jiang BH,Liu LZ.P13K/PTEN signaling in tumorigenesis and anglogenesis.Biochim Biophys Acta,2008,1784(1):150-158.
9Huang S,Shu L,Dilling MB,et al.Sustained activation of the JNK cascade and rapamyein induced apoptcsis are suppressed by p53/p21(Cipl).Mol Cell,2003,11(6):1491-1501.
10Jiang BH,uu LZ.Role of roTOR in anticaneer drug resistance:penspeetives for improved drug treatment.Drug Resist Updat,2008,11(3):63-76.
